Search Result

Results for "

bronchospasm

" in MedChemExpress (MCE) Product Catalog:

By Targets:	Adenosine Receptor (2) Adrenergic Receptor (11) Apoptosis (1) Biochemical Assay Reagents (1) Calcium Channel (1) Drug Intermediate (1) Endogenous Metabolite (1) ERK (3) Ferroptosis (1) Interleukin Related (1) Isotope-Labeled Compounds (2) Leukotriene Receptor (2) mAChR (1) Phosphodiesterase (PDE) (2) Platelet-activating Factor Receptor (PAFR) (1) Prostaglandin Receptor (1) Reactive Oxygen Species (3) Reference Standards (2) SARS-CoV (2) STAT (3)
By Research Areas:	Cancer (7) Cardiovascular Disease (2) Endocrinology (7) Infection (3) Inflammation/Immunology (19) Neurological Disease (3)

By Targets:

Adenosine Receptor (2)

Adrenergic Receptor (11)

Apoptosis (1)

Biochemical Assay Reagents (1)

Calcium Channel (1)

Drug Intermediate (1)

Endogenous Metabolite (1)

ERK (3)

Ferroptosis (1)

Interleukin Related (1)

Isotope-Labeled Compounds (2)

Leukotriene Receptor (2)

mAChR (1)

Phosphodiesterase (PDE) (2)

Platelet-activating Factor Receptor (PAFR) (1)

Prostaglandin Receptor (1)

Reactive Oxygen Species (3)

Reference Standards (2)

SARS-CoV (2)

STAT (3)

By Research Areas:

Cancer (7)

Cardiovascular Disease (2)

Endocrinology (7)

Infection (3)

Inflammation/Immunology (19)

Neurological Disease (3)

Inhibitors & Agonists

Peptides

Natural
Products

Isotope-Labeled Compounds

Cat. No.	Product Name	Target	Research Areas	Chemical Structure

HY-121185

Hexoprenaline	Adrenergic Receptor	Infection Inflammation/Immunology
Hexoprenaline is an orally active and selective β-adrenergic receptor agonist that dilates the bronchi. Hexoprenaline can be used in the study of bronchospasm, including asthma, bronchitis, and emphysema .

HY-118545A

Butamirate citrate	STAT	Inflammation/Immunology Cancer
Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma .

HY-B0004

Doxofylline	Adenosine Receptor Phosphodiesterase (PDE) Reactive Oxygen Species	Inflammation/Immunology
Doxofylline is an orally active PDE IV inhibitor and A1AR antagonist. Doxofylline reduces inflammation in epithelial cells via inhibiting mitochondrial ROS production and amelioration of multiple cellular pathways (NLRP3-TXNIP inflammasome activation). Doxophylline can be used in studies of asthma, chronic obstructive pulmonary disease, and bronchospasm .

HY-N0283

Diacerein 4 Publications Verification Diacerhein; Diacetylrhein	Interleukin Related Calcium Channel	Inflammation/Immunology
Diacerein (Diacerhein), an orally active anthraquinone, reduces production of IL-1 converting enzyme then inhibits the activation of IL-1β by related downstream signaling. Diacerein is an anti-inflammatory and anti-rheumatic drug. Diacerein can relieve bronchospasm and control airway inflammation in asthmatic mice. Diacerein has the potential for slow acting drug in osteoarthritis (SYSADOA) research .

HY-120755

LY290324	Leukotriene Receptor	Inflammation/Immunology
LY290324 is a potent and orally active leukotriene D4 (LTD4) antagonist. LY290324 reduces LTC4, LTD4 and LTE4 (HY-113465)-induced bronchospasm. LY290324 has the potential for the research of antigen-induced bronchospasm .

HY-118545

Butamirate	STAT	Inflammation/Immunology Cancer
Butamirate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate can be used for the study of glioblastoma .

HY-109006

Ilmetropium iodide	mAChR	Neurological Disease
Ilmetropium iodide is an anticholinergic agent. Ilmetropium iodide selectively blocks M-cholinergic receptors of bronchial muscle, reduces or prevents bronchoconstrictor response associated with both cholinergic stimulation, as well as the impact of the factors that provoke bronchospasm. Strength and selectivity of ilmetropium iodide action substantially exceeds Atropine sulfate (HY-B1205A) and Ipratropium bromide (HY-B0241) .

HY-118545AR

Butamirate citrate (Standard)	Reference Standards STAT	Inflammation/Immunology Cancer
Butamirate citrate (Standard) is the analytical standard of Butamirate citrate (HY-118545A). This product is intended for research and analytical applications. Butamirate citrate is an orally active antitussive agent that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect. Butamirate citrate inhibits glioblastoma (GBM) growth and STAT3 activity. Butamirate citrate can be used for the study of glioblastoma .

HY-B0004R

Doxofylline (Standard)	Adenosine Receptor Phosphodiesterase (PDE) Reactive Oxygen Species	Inflammation/Immunology
Doxofylline (Standard) is the analytical standard of Doxofylline. This product is intended for research and analytical applications. Doxofylline is an orally active PDE IV inhibitor and A1AR antagonist. Doxofylline reduces inflammation in epithelial cells via inhibiting mitochondrial ROS production and amelioration of multiple cellular pathways (NLRP3-TXNIP inflammasome activation). Doxophylline can be used in studies of asthma, chronic obstructive pulmonary disease, and bronchospasm .

HY-129546

Eprozinol hydrochloride	Endogenous Metabolite	Inflammation/Immunology
Eprozinol hydrochloride is a compound with antibronchoconstrictor activity. Eprozinol hydrochloride can be used in the study of bronchospasm .

HY-118376

Nestifylline	Biochemical Assay Reagents	Others
Nestifylline is a biochemical reagent. Nestifylline can be used to study respiratory diseases such as bronchospasm .

HY-W721659

Pirquinozol SQ 13,847	Drug Intermediate	Others
Pirquinozol (SQ 13,847) is an orally active anti-allergy agent. Pirquinozol is converted to the oxidation metabolite SQ 12,903, which can exert the maximum activity. Pirquinozol inhibits bronchospasm in rats .

HY-B1037S2

Salbutamol-d9 Albuterol-d₉; AH-3365-d₉	Isotope-Labeled Compounds Adrenergic Receptor	Neurological Disease Endocrinology
Salbutamol-d₉ is the deuterium labeled Salbutamol. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

HY-B1037S

Salbutamol-d3 Albuterol-d₃; AH-3365-d₃	Adrenergic Receptor	Neurological Disease Endocrinology
Salbutamol-d₃ is the deuterium labeled Salbutamol. Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

HY-B1037S3

Salbutamol-d9 acetate Albuterol-d₉ acetate; AH-3365-d₉ acetate	Adrenergic Receptor	Endocrinology
Salbutamol-d₉ (acetate) is the deuterium labeled Salbutamol . Salbutamol is a short-acting β2-adrenergic receptor agonist used for the relief of bronchospasm in conditions such as asthma and chronic obstructive pulmonary disease (COPD).

HY-116051A

16,16-Dimethylprostaglandin F2β 16,16-Dimethyl-PGF2β	Prostaglandin Receptor	Cardiovascular Disease
16,16-Dimethylprostaglandin F2β (16,16-Dimethyl-PGF2β) is an analog of PGF2β (HY-12956B), which is an irratant, but prevents the aspecifically induced bronchospasm .

HY-B0976

Fenoterol Th-1165; Phenoterol	Adrenergic Receptor	Inflammation/Immunology Endocrinology
Fenoterol (Th-1165), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research .

HY-101445R

Trolox (Standard)	Reference Standards Reactive Oxygen Species Ferroptosis Apoptosis	Cancer
Butamirate (citrate) (Standard) is the analytical standard of Butamirate (citrate). This product is intended for research and analytical applications. Butamirate citrate is an orally active cough suppressant that acts centrally through the receptors in the brainstem. Butamirate citrate also reduces the resistance in the airways by inhibiting bronchospasm and anti-inflammatory effect .

HY-164650

Pirodomast Sch 37224	Leukotriene Receptor	Inflammation/Immunology
Pirodomast (Sch 37224) is a leukotriene formation inhibitor. Pirodomast inhibits LTD4 andthromboxane B2 release by anaphylactic guinea pig lung with the IC₅₀ values of 3.9 and 1.9 μM, respectively. Pirodomast can be used for study of asthma .

HY-B0976A

Fenoterol hydrobromide Th-1165a; Phenoterol hydrobromide	Adrenergic Receptor	Inflammation/Immunology Endocrinology
Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research .

HY-B1037

Salbutamol 4 Publications Verification Albuterol; AH-3365	Adrenergic Receptor ERK	Inflammation/Immunology Cancer
Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD) .

HY-B1037B

Salbutamol adipate Albuterol adipate; AH-3365 adipate	Adrenergic Receptor ERK	Inflammation/Immunology Cancer
Salbutamol (Albuterol) adipate is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol adipate promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol adipate is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD) .

HY-B0976AR

Fenoterol (hydrobromide) (Standard) Th-1165a (Standard); Phenoterol (hydrobromide) (Standard)	Adrenergic Receptor	Inflammation/Immunology Endocrinology
Fenoterol (hydrobromide) (Standard) is the analytical standard of Fenoterol (hydrobromide). This product is intended for research and analytical applications. Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research .

HY-B0976AS

Fenoterol-d6 hydrobromide	Isotope-Labeled Compounds Adrenergic Receptor	Inflammation/Immunology Endocrinology
Fenoterol-d₆ (hydrobromide) (Th-1165a-d₆) is the deuterium labeled Fenoterol hydrobromide. Fenoterol hydrobromide (Th-1165a), a sympathomimetic agent, is a selective and orally active β2-adrenoceptor agonist. Fenoterol hydrobromide is an effective bronchodilator and can be used for bronchospasm associated with asthma, bronchitis and other obstructive airway diseases research .

HY-B1037R

Salbutamol (Standard) Albuterol (Standard); AH-3365 (Standard)	Adrenergic Receptor ERK	Inflammation/Immunology Cancer
Salbutamol (Standard) is the analytical standard of Salbutamol. This product is intended for research and analytical applications. Salbutamol (Albuterol) is a short-acting beta-2 adrenergic receptor agonist with oral activity. Salbutamol promotes tumorigenesis of gastric cancer cells through the β2-AR/ERK/EMT pathway. Salbutamol is used to study bronchospasms caused by asthma and chronic obstructive pulmonary disease (COPD) .

HY-117811

(R,R)-MK 287 L-680574	Platelet-activating Factor Receptor (PAFR)	Cardiovascular Disease
(R,R)-MK 287 (L-680574) is a tetrahydrofuran derivative that potently inhibits the binding of [3H]C18-PAF to human platelets, polymorphonuclear leukocytes (PMNs), and lung membranes with Ki values of 6.1, 3.2, and 5.49 nM, respectively. (R,R)-MK 287 potently and selectively inhibits PAF-induced platelet aggregation (ED₅₀=56 nM) and elastase release from PMNs (ED₅₀=4.4 nM). (R,R)-MK 287 inhibits PAF-induced lethality in mice (ED₅₀=0.8 mg/kg, po) and PAF-induced bronchospasm in guinea pigs (ED₅₀=0.18 mg/kg) .

HY-P0012A

Aviptadil acetate 1 Publications Verification Vasoactive Intestinal Peptide acetate salt (human, rat, mouse, rabbit, canine, porcine)	SARS-CoV	Infection Inflammation/Immunology
Aviptadil acetate is an analog vasoactive intestinal polypeptide (VIP) with potent vasodilatory effects. Aviptadil acetate induces pulmonary vasodilation and inhibits vascular SMCs proliferation, platelet aggregation. Aviptadil acetate can be used for the research of pulmonary fibrosis, pulmonary arterial hypertension (PAH) and SARS-CoV-2 caused respiratory failure, et al .

HY-P0012

Aviptadil 1 Publications Verification Vasoactive Intestinal Peptide (human, rat, mouse, rabbit, canine, porcine)	SARS-CoV	Infection Inflammation/Immunology
Aviptadil is an analog vasoactive intestinal polypeptide (VIP) with potent vasodilatory effects. Aviptadil induces pulmonary vasodilation and inhibits vascular SMCs proliferation, platelet aggregation. Aviptadil can be used for the research of pulmonary fibrosis, pulmonary arterial hypertension (PAH) and SARS-CoV-2 caused respiratory failure, et al .

Cat. No.	Product Name	Target	Research Area